-
Affinity-Purified Goat Anti-Mouse IgG (H+L) for CRC
2026-09-15
Use this HRP Conjugated secondary antibody to connect mouse-primary immunodetection with Western blot, ELISA, and tissue-based analysis of AQP9 and ZHX2 in KRASG12V colorectal cancer research. Practical dilution, storage, control, and troubleshooting guidance helps distinguish genuine biology from assay-generated signal.
-
HOBt Workflows for Precise Amide Bond Formation
2026-09-15
HOBt supports mild, high-fidelity amide bond formation in peptide synthesis and small-molecule discovery. This practical guide connects active-ester chemistry with the indazole glucagon receptor antagonist workflow, offering actionable setup, optimization, and troubleshooting advice.
-
Glycogen Colorimetric Assay Kit II Workflow
2026-09-14
Build a reproducible glycogen workflow for exercise, circadian, metabolic disease, and complex biological samples. The Glycogen Colorimetric Assay Kit II combines enzymatic hydrolysis with 450 nm colorimetric detection, helping laboratories compare liver and muscle glycogen without relying on oxidase-only readouts.
-
7-dehydro Cholesterol: From Sterol to Strategy
2026-09-14
7-dehydro Cholesterol is more than a cholesterol intermediate: it is a controllable probe of sterol flux, UVB-driven vitamin D3 formation, oxidative sensitivity, and disease-relevant biology. This thought-leadership guide connects mechanistic insight with translational strategy, using dhcr7-edited grass carp as an example of how sterol biology can inform antiviral research and engineered traits.
-
Cyclo (-RGDfC) for αvβ3 Assays
2026-09-13
Cyclo (-RGDfC), also called c(RGDfC), converts αvβ3 receptor biology into practical adhesion, migration, angiogenesis, and delivery assays. This guide connects product handling with comparative controls, canine osteosarcoma study design, and troubleshooting strategies for more interpretable cancer research.
-
MRSA Research: Mechanisms, Epidemiology, and Methods
2026-09-12
Turner and colleagues integrate molecular, epidemiological, and clinical evidence to explain why MRSA remains a globally adaptable pathogen rather than a single pandemic clone. The review’s main practical implication is that Staphylococcus aureus infection research should connect resistance genotype, strain transmission, colonization, infection phenotype, and clinical source control.
-
Geneticin: Selection Workflows and Assay Insights
2026-09-12
Geneticin supports rigorous neomycin-resistance selection while also enabling carefully controlled cell-based Dengue virus inhibition studies. This guide connects practical G418 Sulfate workflows with the EBV–NPC plasticity findings from a landmark HDAC study, emphasizing assay design, controls, and troubleshooting.
-
Mitoxantrone Targets the ERα DBD–LBD Interface
2026-09-11
Wang and colleagues identify an allosteric binding site between the DNA-binding and ligand-binding domains of estrogen receptor α (ERα), showing that mitoxantrone can disrupt receptor conformation, promote cytoplasmic redistribution, and trigger proteasomal degradation. The work suggests a mechanism for suppressing wild-type and endocrine-resistant ERα mutants that differs from conventional hormone-pocket targeting and from mitoxantrone’s established DNA topoisomerase II inhibitor activity.
-
Prochlorperazine for Acute Mountain Sickness Prevention
2026-09-11
This 2024 Trials protocol proposes a randomized, double-blind test of prochlorperazine maleate as chemoprophylaxis for acute mountain sickness during rapid ascent. Its main contribution is a mechanistically reasoned repurposing strategy that links migraine treatment, respiratory stimulation, and altitude-illness prevention while defining a controlled field-based outcome framework.
-
O6-Benzylguanine: MGMT Inhibitor Guide
2026-09-10
O6-Benzylguanine is an irreversible MGMT inhibitor that blocks a key pathway for repairing O6-alkylguanine DNA lesions. Its principal research use is sensitization to alkylating agents in cancer chemotherapy research, with interpretation dependent on MGMT status, treatment schedule, and appropriate solvent controls.
-
Homoharringtonine: Mechanism and Research Evidence
2026-09-10
Homoharringtonine is a cytotoxic alkaloid and protein synthesis inhibitor that acts through eukaryotic 80S ribosome binding. Evidence supports its use in leukemia research and cancer biology, while SARS-CoV-2 antiviral research remains an early translational application requiring careful cytotoxicity controls.
-
FPH1 (BRD-6125) for Functional Hepatocyte Expansion
2026-09-09
FPH1 (BRD-6125) supports a more informative hepatocyte proliferation assay by pairing cell expansion with albumin, CYP3A4, and AFP readouts. This guide translates the compound into practical workflows for primary human hepatocyte culture, iPS-derived hepatocyte models, and exploratory gene-regulation studies while emphasizing dosing, handling, and troubleshooting.
-
Plk1 Control of p31comet in Mitotic Checkpoint Disassembly
2026-09-09
The reference study identifies Polo-like kinase 1 (Plk1) as a direct negative regulator of p31comet–TRIP13-mediated mitotic checkpoint complex disassembly. By mapping the relevant phosphorylation site to S102 and testing an S102A mutant, the work provides a mechanistic explanation for how cells may prevent premature checkpoint silencing during active mitosis.
-
Cabazitaxel (XRP6258): Practical Workflow Guide
2026-09-08
Cabazitaxel (XRP6258, SKU B2157) is a water-insoluble taxane derivative for controlled antiproliferative assays and studies of taxane-resistant cancer models. This guide covers solvent selection, preparation, exposure planning, and QC while defining why direct aqueous preparation and long-term solution storage should be avoided.
-
Melatonin Targets RIPK3 in Atrazine Kidney Injury
2026-09-08
The reference study identifies RIPK3-dependent necroptosis as a central mechanism of atrazine-induced renal tubular injury and shows that melatonin suppresses this pathway. By combining in vivo and in vitro injury models with RIPK3 knockdown and computational structural analysis, the work links melatonin treatment to reduced necroptotic signaling, mitochondrial dysfunction, and inflammation.